These are the cookies we use on our website. You can configure your preferences and choose how you want your data to be used for the following purposes.
Own / Mandatory / Technical
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences or filling in forms.
These cookies collect information regarding the use of the web page, such as time spent on the page and content visited, to measure its performance and improve navigation.
We’re pleased to release Alantra’s Q3 2022 Digital Health Quarterly Market Review.
Inside, you’ll find a discussion of key highlights and trends, including summaries on news and economic developments, capital markets, M&A, private placement activity, valuations, and our proprietary data and insights in the Digital Health space.
Key highlights from the report include:
Our Digital Health Index lagged the broader market, but saw revenue and profitability growth well in the double digits
The LTM revenue multiple for our public index ended the quarter at 3.9x
By volume, private placement activity is at a near-record high. The $6B raised represents a 40% recovery over Q2
M&A activity totaled $20B, nearly half of which was represented by two deals. Valuations edged slightly above 6x revenue
Across both private placements and M&A, Life Sciences vendors have seen an uptick. Activity was well dispersed across subsectors